Dilution of Equity Value from the Exercise of Stock Acquisition Rights
First written in FY2021. 14 of 15 entries say "Materialised", first in FY2022-Q3. Latest entry: 2026-10-07.
Brains Technology moved to the "Worse" side of this theme in 2022, 2 years after the typical company in this theme (2020).
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
69 other companies' latest entry also says "Materialised".
- FY2026-H1MaterialisedAnnual report
「1 August 2025– 31 January 2026 (Note) 14,400 5,960,000 2,505 621,031 2,505 586,031 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the six-month accounting period, the total number of issued shares increased by 14,400 as a result of the exercise of stock acquisition rights, while capital stock and the capital reserve each increased by ¥2.505 million. Dilution continues to occur. - FY2025-H1MaterialisedAnnual report
「1 August 2024– 31 January 2025 (Note) 35,000 5,605,600 2,250 601,526 2,250 566,526 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the six-month accounting period, the total number of issued shares increased by 35,000 as a result of the exercise of stock acquisition rights, and dilution continues to occur. - FY2024MaterialisedAnnual report
「As of the date of filing this document, potential shares represented 10.1% of the total number of issued shares. If these stock acquisition rights are exercised, the value per share of the company’s stock will be diluted, which may affect the company’s share price.」
During the fiscal year, the number of shares increased by 60,700 as a result of the exercise of stock acquisition rights, indicating that dilution continues to occur in practice. The potential share ratio declined from 12.8% previously to 10.1%. - FY2024-Q3MaterialisedAnnual report
「1 February 2024–30 April 2024 (Note) 7,100 5,570,600 1,315 599,276 1,315 564,276 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the third quarter, the total number of issued shares increased by 7,100 as a result of the exercise of stock acquisition rights, and dilution continues to occur. - FY2024-Q2MaterialisedAnnual report
「This was attributable to ¥16.560 million in proceeds from the issuance of shares through the exercise of stock acquisition rights and ¥5.000 million in outflows for the repayment of long-term borrowings.」
During the six-month period ended in the current second quarter, the company generated ¥16.560 million in proceeds from the issuance of shares through the exercise of stock acquisition rights. The company also disclosed an increase of 300 shares between 1 November 2023 and 31 January 2024 in its share information, confirming that dilution continues to occur. - FY2024-Q1MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
The total number of issued shares increased by 53,300 as a result of the exercise of stock acquisition rights between 1 August and 31 October 2023, and dilution continues to occur. - FY2023-Q3MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
The company disclosed that the total number of issued shares increased by 40,300 as a result of the exercise of stock acquisition rights between 1 February and 30 April 2023, confirming that dilution continues to occur. - FY2023-Q2MaterialisedAnnual report
「This increase was due to the exercise of stock acquisition rights. 2. Between 1 February 2023 and 28 February 2023, the total number of shares issued increased by 40,300 shares through the exercise of stock acquisition rights, while capital stock and the capital reserve each increased by ¥2,060 thousand.」
From November 2022 to January 2023, the number of shares increased by 16,100, followed by a further increase of 40,300 shares in February 2023, indicating that dilution from the exercise of stock acquisition rights continues to occur in practice. - FY2023-Q1MaterialisedAnnual report
「This increase was due to the exercise of stock acquisition rights. 2. Between 1 November 2022 and 30 November 2022, the total number of shares issued increased by 16,100 shares through the exercise of stock acquisition rights, while capital stock and the capital reserve each increased by ¥1,720 thousand.」
The number of shares increased by 75,000 through the exercise of stock acquisition rights between August and October 2022, and by a further 16,100 in November, meaning that dilutive events continued to occur in practice. - FY2022MaterialisedAnnual report
「As of the date of submission of this document, potential shares represented 12.8% of the total number of shares issued. If these stock acquisition rights are exercised, the value per share of our stock will be diluted, which could affect our share price.」
The number of shares increased by 4,100 through the exercise of stock acquisition rights during the fiscal year, meaning that a dilutive event had actually occurred. The percentage of potential shares decreased from 14.7% in the previous disclosure to 12.8%. - FY2022-Q3MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
The company disclosed that 4,100 shares increased through the exercise of stock acquisition rights between 1 February and 30 April 2022, meaning that an event causing dilution of per-share value had actually occurred. - FY2021First statedAnnual report
「As of the date of submission of this document, potential shares represented 14.7% of the total number of shares issued. If these stock acquisition rights are exercised, the value per share of our stock will be diluted, which could affect our share price.」
The company grants stock acquisition rights as incentives for directors and employees.